Max Healthcare Institute Limited has scheduled a series of investor conferences with Citi and Jefferies for June 2026. The Chairman and Managing Director and Senior Management of the company will participate in these meetings to engage with investors. The company confirmed that no unpublished price sensitive information will be disclosed during the conferences.

Conference Schedule

The investor conferences are organized under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The schedule includes physical meetings in Mumbai and New York.

Key Disclosures

The company stated that the schedule is subject to changes due to exigencies on the part of the investors or the company. The disclosure was made by Dhiraj Aroraa, SVP - Company Secretary and Compliance Officer. This information has been hosted on the company's website.

Max Healthcare Institute Limited has reported a net revenue of ₹10,065 crore for the financial year 2026, marking a 16% year-on-year growth. The company disclosed its operational and financial performance for FY26 in an investor presentation filed with the stock exchanges. The presentation was made in connection with the upcoming UBS Asian Investment Conference 2026, scheduled for May 27 and 28, 2026, in Hong Kong.

Financial Performance

For the year ended March 31, 2026, Max Healthcare recorded a profit after tax of ₹1,631 crore. The network's operating EBITDA stood at ₹2,638 crore, with an EBITDA margin of 26.2%. The company reported a pre-tax return on capital employed (ROCE) of 27.7% for FY26.

Operational Highlights

Max Healthcare maintained its position as India's second-largest hospital chain by revenue and EBITDA. The company operates a network of 21 healthcare facilities comprising over 6,000 beds. During FY26, the hospital chain performed approximately 52,900 cardiac procedures, 15,000 neurosurgeries, and 42,800 oncology surgeries.

The average revenue per occupied bed (ARPOB) for FY26 was ₹78,000, while occupancy levels stood at 75%. The company added approximately 1,300 beds across different geographies in the last 18 months, including acquisitions in Lucknow, Nagpur, and Noida.

Expansion Strategy

The company outlined a strategy to expand bed capacity by 8,400+ beds, with approximately 4,000 beds expected to be added in the next 3-4 years. Key expansion projects include the newly commissioned Max Mohali Tower 2, Nanavati-Max Tower 2 (Phase 1), and Max Smart Tower 2. The company is also developing greenfield hospitals in Gurgaon and Lucknow.

Conference Details

Max Healthcare's Chairman and Managing Director, Abhay Soi, is scheduled to attend the UBS Asian Investment Conference 2026. The event will be held in a physical format at the Four Seasons Hotel in Hong Kong, allowing for one-on-one and group interactions with investors.